Description of Sofosvel
is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C
treatment. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has
been approved by US FDA & European Commission for treatment of patients
with all genotypic Chronic Hepatitis C virus infection.
Sofosvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).
Sofosvel is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infections
or without cirrhosis or with compensated cirrhosis
decompensated cirrhosis for use in combination with Ribavirin
|Generic||Brand Name||Formulation & Strength||Pack Size|
|Sofosbuvir+Velpatasvir||Sofosvel||Solid dosage form(Tablet) ( 400 mg )||1x6's|
Website Prescribing Information Order Now